Skip to main content
PMC home page
Tobacco Control logoLink to Tobacco Control
. 2000 Jun;9(Suppl 2):ii60–ii63. doi: 10.1136/tc.9.suppl_2.ii60

Cigarette consumption and sales of nicotine replacement products

T Hu, H Sung, T Keeler, M Marciniak
PMCID: PMC1766286  PMID: 10841593

Abstract

BACKGROUND—The first nicotine replacement product, Nicorette Gum, was marketed in 1984 as an adjuvant to help smokers quit smoking. In 1992, sales of nicotine patches were begun. Before 1996, nicotine gums and nicotine patches were prescribed by physicians and supplemented with behavioural counselling. Since 1996, nicotine gums and patches became available over the counter.
OBJECTIVES—To examine the effect of sales of nicotine replacement products on national cigarette consumption.
DESIGN—National time series quarterly cigarette consumption, sales of nicotine gums and patches data between 1976 and 1998 are used to estimate a time series autoregressive moving average intervention model.
PARTICIPANTS—National reported statistics.
MAIN OUTCOME MEASURES—Per capita cigarette sales.
RESULTS—A 10% increase in sales of nicotine replacement products will lead to a 0.04% reduction in cigarette sales. The model indicates that a 0.076% reduction in cigarette consumption is associated with the availability of nicotine patches after 1992. The over the counter dummy variable (after 1996) has a negative sign, but is not significant, perhaps due to only a few quarters of data in the study period.
CONCLUSIONS—Nicotine replacement products (nicotine gums and nicotine patches) play a significant role in reducing cigarette consumption, in addition to the negative effect of increasing cigarette price and the overall trend of declining cigarette consumption (as reflected by the time trend variable). The findings of this study suggest that additional efforts for promoting sales of nicotine replacement products will be another effective alternative to discouraging cigarette consumption.


Keywords: nicotine replacement products; nicotine gum; nicotine patches; cigarette consumption

Full Text

The Full Text of this article is available as a PDF (116.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abelin T., Buehler A., Müller P., Vesanen K., Imhof P. R. Controlled trial of transdermal nicotine patch in tobacco withdrawal. Lancet. 1989 Jan 7;1(8628):7–10. doi: 10.1016/s0140-6736(89)91671-1. [DOI] [PubMed] [Google Scholar]
  2. Benowitz N. L. Treating tobacco addiction--nicotine or no nicotine? N Engl J Med. 1997 Oct 23;337(17):1230–1231. doi: 10.1056/NEJM199710233371710. [DOI] [PubMed] [Google Scholar]
  3. Cromwell J., Bartosch W. J., Fiore M. C., Hasselblad V., Baker T. Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation. Agency for Health Care Policy and Research. JAMA. 1997 Dec 3;278(21):1759–1766. [PubMed] [Google Scholar]
  4. Curry S. J., Grothaus L. C., McAfee T., Pabiniak C. Use and cost effectiveness of smoking-cessation services under four insurance plans in a health maintenance organization. N Engl J Med. 1998 Sep 3;339(10):673–679. doi: 10.1056/NEJM199809033391006. [DOI] [PubMed] [Google Scholar]
  5. Daughton D. M., Heatley S. A., Prendergast J. J., Causey D., Knowles M., Rolf C. N., Cheney R. A., Hatlelid K., Thompson A. B., Rennard S. I. Effect of transdermal nicotine delivery as an adjunct to low-intervention smoking cessation therapy. A randomized, placebo-controlled, double-blind study. Arch Intern Med. 1991 Apr;151(4):749–752. [PubMed] [Google Scholar]
  6. Fiore M. C., Jorenby D. E., Baker T. B., Kenford S. L. Tobacco dependence and the nicotine patch. Clinical guidelines for effective use. JAMA. 1992 Nov 18;268(19):2687–2694. [PubMed] [Google Scholar]
  7. Fiscella K., Franks P. Cost-effectiveness of the transdermal nicotine patch as an adjunct to physicians' smoking cessation counseling. JAMA. 1996 Apr 24;275(16):1247–1251. [PubMed] [Google Scholar]
  8. Kenford S. L., Fiore M. C., Jorenby D. E., Smith S. S., Wetter D., Baker T. B. Predicting smoking cessation. Who will quit with and without the nicotine patch. JAMA. 1994 Feb 23;271(8):589–594. doi: 10.1001/jama.271.8.589. [DOI] [PubMed] [Google Scholar]
  9. Kornitzer M., Boutsen M., Dramaix M., Thijs J., Gustavsson G. Combined use of nicotine patch and gum in smoking cessation: a placebo-controlled clinical trial. Prev Med. 1995 Jan;24(1):41–47. doi: 10.1006/pmed.1995.1006. [DOI] [PubMed] [Google Scholar]
  10. Lewis S. F., Piasecki T. M., Fiore M. C., Anderson J. E., Baker T. B. Transdermal nicotine replacement for hospitalized patients: a randomized clinical trial. Prev Med. 1998 Mar-Apr;27(2):296–303. doi: 10.1006/pmed.1998.0266. [DOI] [PubMed] [Google Scholar]
  11. Pierce J. P., Gilpin E., Farkas A. J. Nicotine patch use in the general population: results from the 1993 California Tobacco Survey. J Natl Cancer Inst. 1995 Jan 18;87(2):87–93. doi: 10.1093/jnci/87.2.87. [DOI] [PubMed] [Google Scholar]
  12. Tønnesen P., Nørregaard J., Simonsen K., Säwe U. A double-blind trial of a 16-hour transdermal nicotine patch in smoking cessation. N Engl J Med. 1991 Aug 1;325(5):311–315. doi: 10.1056/NEJM199108013250503. [DOI] [PubMed] [Google Scholar]
  13. Warner K. E., Slade J., Sweanor D. T. The emerging market for long-term nicotine maintenance. JAMA. 1997 Oct 1;278(13):1087–1092. [PubMed] [Google Scholar]
  14. Wasley M. A., McNagny S. E., Phillips V. L., Ahluwalia J. S. The cost-effectiveness of the nicotine transdermal patch for smoking cessation. Prev Med. 1997 Mar-Apr;26(2):264–270. doi: 10.1006/pmed.1996.0127. [DOI] [PubMed] [Google Scholar]

Articles from Tobacco Control are provided here courtesy of BMJ Publishing Group

RESOURCES